256

OBSERVATIONAL, CAUSAL RELATIONSHIP AND SHARED GENETIC BASIS BETWEEN CHOLELITHIASIS AND GASTROESOPHAGEAL REFLUX DISEASE: EVIDENCE FROM A COHORT STUDY AND COMPREHENSIVE GENETIC ANALYSIS

Date
May 18, 2024


Background
Cholelithiasis and gastroesophageal reflux disease (GERD) contributed to significant health concern. Research on the relationship between cholelithiasis and GERD is scarce, with inconsistent and insufficient findings. Besides, the causality and underlying biological connections remain unclear. In this study, we comprehensively investigate the potential observational, causal and genetic relationships between cholelithiasis and GERD with observational and genetic-level approaches.
Methods
Based on the large-scale prospective cohort of approximately 420,000 samples from UK Biobank, we firstly investigated the phenotypic correlations. Then, by leveraging the genome-wide summary statistics of cholelithiasis (N = 334,277) and GERD (N = 332,601), we evaluated the bidirectional causal associations between them. Subsequently, we applied a series of genetic analyses to assess the global and local genetic correlation, shared loci and genes between cholelithiasis and GERD to further explore the underlying genetic connections.
Results
Findings from the prospective cohort study revealed a significant increased risk of GERD in individuals with cholelithiasis (Hazard ratio (HR) = 1.99, 95% confidence interval (CI) = 1.89-2.10). Additionally, participants with GERD had a higher risk of incident cholelithiasis (HR = 2.30, 95% CI = 2.18-2.44). The Mendelian randomization study indicated the causal effect of genetic liability to cholelithiasis on the incidence of GERD (Odds ratio = 1.07, 95% CI = 1.05-1.10). Besides, cholelithiasis and GERD exhibited a strong genetic association. Cross-trait meta-analyses identified 5 novel independent loci shared between cholelithiasis and GERD. Three shared genes including SUN2, CBY1 and JOSD1 were further identified as novel risk genes in the transcriptome-wide association studies.
Conclusions
Our comprehensive cohort study and genetic analyses have demonstrated a significant causal association between cholelithiasis and GERD. The elucidation of the shared genetic basis underlying the phenotypic relationship of these two complex phenotypes offers new insights into the intrinsic linkage between cholelithiasis and GERD, encouraging future research on their biological mechanisms and novel therapeutic strategies.

Tracks

Related Products

Thumbnail for A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
Thumbnail for CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER
CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER
BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…
Thumbnail for RHO GTPASE SIGNALING-BASED GENE SIGNATURE ENABLES EVALUATION OF HEPATOCELLULAR CARCINOMA IMMUNE INFILTRATION, THERAPEUTIC BENEFIT, AND PAN-CANCER PROGNOSIS
RHO GTPASE SIGNALING-BASED GENE SIGNATURE ENABLES EVALUATION OF HEPATOCELLULAR CARCINOMA IMMUNE INFILTRATION, THERAPEUTIC BENEFIT, AND PAN-CANCER PROGNOSIS
BACKGROUND: Alcohol-associated hepatitis (AH) is the active inflammatory state of alcohol-associated liver disease (ALD). AH varies in severity from mild to severe with mortality rates reaching 30-50% in severe AH…